Kirby's 1st time in Canada!

[Guest guest]

I wanted to give you a heads up that Author of " Evidence of Harm " ,

Kirby (who also just won a prestigious journalism award) will be in Canada

for a tour in 6 Eastern cities for the first time ever beginning this March!

Also, I wanted to ask you to take our special survey regarding 's

upcoming events.

To take the survey press the link below:

http://autismtoday.com/survey_kirby.asp

Futhermore, will be signing his books as well as discussing the

following during his full day

presentation:

PART I - THE BASICS -

Mercury and its many types, routes of exposure, use in medicine,

environmental exposures, etc.

Also, the many forms of toxic reactions mercury can cause.

PART II - THE MERCURY-AUTISM DEBATE -

Science that supports and refutes a link between mercury and autism --

including the current debate in Canada. History of thimerosal, and its

current use in Canadian, US and global vaccines.

PART III - CURRENT INVESTIGATIONS AND

ACTIVITIES IN THE US -

US Senate Action, Lawsuits, New Bills, New Research Funding, New CDC

Thimerosal Study, Call for a New IOM Hearing, Media Coverage, etc.

CONTROVERSIAL NEW TREATMENTS FOR AUTISM - Chelation, Vitamin B12, Hyperbaric

Oxygen Therapy, etc

For complete event listings and

futher information, please go to:

http://www.autismevents.com

[ ] Yeast used to open nasal cells

http://news.bbc.co.uk/1/hi/health/4674386.stm

Yeast used to open cells of nose to allow in insulin.

Yeast 'could allow insulin spray'

More than 1.7m people in England have diabetes

Diabetes patients could be able to receive insulin via a nasal spray

using yeast, scientists believe.

Leeds University researchers found the fungus, traditionally used to

make beer and bread, opened nasal cells to allow insulin to pass through

nose tissue.

They hope it will allow a spray to be developed to replace injections.

A Diabetes UK spokeswoman said it would welcome " any safe, effective

advances which make the treatment of diabetes easier and more comfortable " .

Getting insulin into the bloodstream through the nose is tricky

because the layers of tissue lining the nose, known as the nasal mucosa, can

block the molecule.

Laboratory results show that yeast cells successfully enhanced

the penetration of insulin

Lead researcher Fuller

But in preliminary research, the scientists found that yeast, which is

non-toxic, opened up the tight junctions between nasal cells.

Lead researcher Fuller said: " Transport of large molecules, such

as insulin, through the nasal mucosa is limited because of the tight

structure of the cell layer which forms an impenetrable barrier.

" Our laboratory results show that yeast cells successfully enhanced

the penetration of insulin. "

The team, which presented its findings at the British Pharmaceutical

Conference in Manchester, said more research was needed.

Drug protection

Researchers also said they were looking at yeast's properties as a

drug delivery system.

They said it might be possible to encapsulate active drugs inside

yeast cells to protect them until they get to the site of action.

Zoe on, care advisor at Diabetes UK, said: " In the UK, there are

around 700,000 people with diabetes whose only treatment option is daily

insulin injections.

" Although this nasal therapy is in its very early stages, Diabetes UK

welcomes any safe, effective advances which make the treatment of diabetes

easier and more comfortable.

" We will await the results of the first clinical trials with

interest. "